Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients

Background. Cardiovascular disease is the principal cause of mortality in older individuals, and more than 80% of deaths due to coronary heart disease or stroke occur in patients over 65 years of age. Hyperlipidemia is one of the main modifiable risk factors for cardiovascular disease. Current guide...

Full description

Bibliographic Details
Main Authors: N. K. Wenger, S. J. Lewis
Format: Article
Language:English
Published: Hindawi Limited 2010-01-01
Series:Current Gerontology and Geriatrics Research
Online Access:http://dx.doi.org/10.1155/2010/915296
id doaj-8828c6442a3e4c6f8d716a8d32789ae0
record_format Article
spelling doaj-8828c6442a3e4c6f8d716a8d32789ae02020-11-24T21:03:58ZengHindawi LimitedCurrent Gerontology and Geriatrics Research1687-70631687-70712010-01-01201010.1155/2010/915296915296Use of Statin Therapy to Reduce Cardiovascular Risk in Older PatientsN. K. Wenger0S. J. Lewis1Grady Memorial Hospital, School of Medicine, Emory University, Atlanta, GA 30303, USADepartment of Medicine, Northwest Cardiovascular Institute, Portland, OR 97210, USABackground. Cardiovascular disease is the principal cause of mortality in older individuals, and more than 80% of deaths due to coronary heart disease or stroke occur in patients over 65 years of age. Hyperlipidemia is one of the main modifiable risk factors for cardiovascular disease. Current guidelines recommend the use of statins to reduce low-density lipoprotein cholesterol to appropriate targets based on an individual's cardiovascular risk, and clearly state that older age should not be a barrier to treatment. Despite extensive evidence demonstrating clear benefit with statin therapy in older individuals, this population remains chronically undertreated. Scope. This paper provides an overview of the current evidence available regarding the efficacy and safety of statin therapy to reduce cardiovascular risk in older patients. We use hypothetical case studies to address some of the questions frequently posed by physicians responsible for the cardiovascular health of older patients. Conclusions. Various factors may account for the failure to provide appropriate treatment, including a lack of awareness of clinical benefits and perceived safety issues. However, if current guidelines are followed and older patients treated to appropriate LDL-C goals, the likelihood of cardiovascular events will be reduced in this high-risk population. Employing an evidence-based approach to the management of cardiovascular risk in older patients is likely to yield benefits in terms of overall cardiovascular burden.http://dx.doi.org/10.1155/2010/915296
collection DOAJ
language English
format Article
sources DOAJ
author N. K. Wenger
S. J. Lewis
spellingShingle N. K. Wenger
S. J. Lewis
Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients
Current Gerontology and Geriatrics Research
author_facet N. K. Wenger
S. J. Lewis
author_sort N. K. Wenger
title Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients
title_short Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients
title_full Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients
title_fullStr Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients
title_full_unstemmed Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients
title_sort use of statin therapy to reduce cardiovascular risk in older patients
publisher Hindawi Limited
series Current Gerontology and Geriatrics Research
issn 1687-7063
1687-7071
publishDate 2010-01-01
description Background. Cardiovascular disease is the principal cause of mortality in older individuals, and more than 80% of deaths due to coronary heart disease or stroke occur in patients over 65 years of age. Hyperlipidemia is one of the main modifiable risk factors for cardiovascular disease. Current guidelines recommend the use of statins to reduce low-density lipoprotein cholesterol to appropriate targets based on an individual's cardiovascular risk, and clearly state that older age should not be a barrier to treatment. Despite extensive evidence demonstrating clear benefit with statin therapy in older individuals, this population remains chronically undertreated. Scope. This paper provides an overview of the current evidence available regarding the efficacy and safety of statin therapy to reduce cardiovascular risk in older patients. We use hypothetical case studies to address some of the questions frequently posed by physicians responsible for the cardiovascular health of older patients. Conclusions. Various factors may account for the failure to provide appropriate treatment, including a lack of awareness of clinical benefits and perceived safety issues. However, if current guidelines are followed and older patients treated to appropriate LDL-C goals, the likelihood of cardiovascular events will be reduced in this high-risk population. Employing an evidence-based approach to the management of cardiovascular risk in older patients is likely to yield benefits in terms of overall cardiovascular burden.
url http://dx.doi.org/10.1155/2010/915296
work_keys_str_mv AT nkwenger useofstatintherapytoreducecardiovascularriskinolderpatients
AT sjlewis useofstatintherapytoreducecardiovascularriskinolderpatients
_version_ 1716772562618286080